SYNOPSYS INC (SNPS): what the price requires

Generated: 2026-07-14 · Exported: 2026-07-16 · Source: https://boothcheck.com/report/SNPS

Headline

Field	Value
Ticker	SNPS
Company	SYNOPSYS INC
Sector / Industry	Technology
Current price	$433.60/sh
Composition	Time-based products revenue 49% / Upfront products revenue 28% / Maintenance and service revenue 22%

What The Price Requires (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

Field	Value
Inversion basis	whole-company
Operating margin today	10.8%
Must persist for	16.0y
Multiple paid	106x operating income

Solve inputs: computed at a 9.5% cost of capital; growth searched up to the 25% self-funding ceiling; each 1pp moves the implied horizon ~2.5 years.

How unusual the bet is: elevated

Reference	Value
vs own history	+1.01σ
sustained it ~10 years at this level	15%
implied end-window share	0%

Valuation X-Ray

Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

Family	Median price/FV	Models	Reads
Asset	6.31x	1	expensive
Earnings	6.49x	2	expensive
Relative	2.93x	3	expensive
Growth	0.82x	3	justifies

Families that justify the price: Growth Families that call it expensive: Asset, Earnings, Relative

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.3%); the inversion above states its own rate.

Per-Model Detail (n=9)

Model	Family	FV	Price/FV	Applicable	Methodology
DCF Perpetual Growth	Growth	$552.97	0.78x	yes	FCF base $2.9B, growth 25% (input: historical growth), terminal g 4.0%, WACC 8.3%, 7yr projection
DCF Exit Multiple	Growth	$481.13	0.90x	yes	Exit EV/EBITDA: 84.4x / 86.4x / 88.4x (bear / base = today's held flat / bull), 7yr
Relative Valuation	Relative	$148.13	2.93x	yes	P/E 77x (blended: static sector reference 35x + trailing (TTM) 401x), scenarios: 61.6x / 77.0x / 92.4x (bear / base = reference held flat / bull), EV/EBITDA 43.43x
Simple DDM	Growth	—	—	no	—
Two-Stage DDM	Growth	—	—	no	—
Simple Excess Return	Asset	$11.69	37.09x	yes	BV/sh $158.63, ROE (TTM) 0.7%, ke 9.3% (excluded from median)
Two-Stage Excess Return	Asset	$6.07	71.43x	yes	5yr excess ROE then converge to ke=9.3% (excluded from median)
Discounted Future Market Cap	Growth	$531.69	0.82x	yes	Rev $8.7B, growth 30% (input: historical growth; tapered), Terminal P/S: 7.7x / 9.6x / 11.5x (bear / base = today's held flat / bull, cap 12x)
Growth-Adjusted P/E	Relative	—	—	no	—
Margin Trajectory	Growth	—	—	no	—
Earnings Power Value	Earnings	$17.15	25.28x	yes	Normalized EBIT (5y avg op income, one-time charges added back) $1.17B × (1−12%) / WACC 8.3% → EPV (no growth) (excluded from median)
Residual Income	Asset	$4.30	100.84x	yes	BV $158.63 + 5yr PV of (ROE (TTM) 0.7% − Kₑ 9.3%) × BV; BV grows 0.4%/yr (excluded from median)
Graham Number	Asset	$68.69	6.31x	yes	√(22.5 × EPS $1.32 × BVPS $158.63) — Graham's conservative floor
EV/EBITDA Relative	Relative	$94.41	4.59x	yes	EBITDA $1.06B × sector EV/EBITDA 25.0x
FCF Yield	Earnings	$104.58	4.15x	yes	FCF $2633.8M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF Yield	Earnings	$49.09	8.83x	yes	SBC-adj FCF $1.65B (FCF $2.63B − SBC $0.99B) capitalized at Kₑ
Ben Graham Formula	Earnings	$1.11	390.63x	yes	EPS $1.32 × (8.5 + 2×-5.0%) × (4.4 / 5.3%) (excluded from median)
ROIC-Justified P/B	Asset	$5.18	83.71x	yes	BV $158.63 × (ROIC 0.3% / WACC 8.3%) (excluded from median)
P/Sales Sector	Relative	$361.37	1.20x	yes	Revenue $8.68B × sector P/S 8.0x
PEG Fair Value	Relative	—	—	no	—
Earnings Yield	Earnings	$14.29	30.34x	yes	EPS $1.32 / required return 9.3% (Rf 4.3% + ERP 5.0%) (excluded from median)
Funds From Operations Multiple	Relative	—	—	no	—
Clinical Phase NPV	Growth	—	—	no	—
Merton	Asset	—	—	no	—
V5 Mechanical	—	—	—	no	—

Solvency

Field	Value
Net debt	$7.6b
Net debt / NOPAT (after-tax)	9.97x
Net debt / operating income (pre-tax)	8.73x
Interest coverage	1.6x
Share count CAGR (dilution)	5.3%
Burning cash	no

Bullet Takeaways

• Synopsys is the certified toll booth of chip design, its tools embedded in "major foundries' manufacturing processes" per its own 10-K (accession 0000883241-25-000028), now extended into physics simulation by the Ansys acquisition that management expects to add about $2.96 billion of fiscal 2026 revenue.
• The risk is leverage stacked under a deal-year fog: $7.55 billion of net debt with GAAP interest coverage near 1.0 times, a share count up about 5.3 percent a year, and a price at roughly 108 times record-basis trailing operating income that only the forward-growth methods can defend.
• Watch the fiscal third-quarter report in late August 2026 against raised guidance of $9.625 to $9.705 billion revenue and $14.72 to $14.80 non-GAAP EPS, with Ansys cost-synergy progress the swing item.

Bull Case

Trailing multiples are currently measuring the wrong Synopsys. The GAAP income statement is digesting the largest acquisition in EDA history, with purchase accounting and integration costs compressing reported operating income to $610 million on EDGAR's trailing tally, while the operating reality runs far ahead of it: second-quarter fiscal 2026 revenue of $2.276 billion beat the company's own guidance, the EDA segment grew 8 percent year over year, and the non-GAAP operating margin, as the company defines and discloses it, reached 39.5 percent. A backward-looking model sees a levered company earning thin profits; the business underneath is the toll booth on advanced silicon design, collecting from every AI chip program in existence, now bundled with Ansys simulation.

What the static frames structurally cannot price is the franchise position, and the filings describe it well. The 10-K explains that "Designing ICs involves many complex steps, including, among others architecture definition" and onward through a workflow in which Synopsys tools are certified against "major foundries' manufacturing processes" (accession 0000883241-25-000028); that foundry-certification loop is the moat, because a chip team cannot tape out on an uncertified flow. The time-based revenue model turns that position into a recurring stream, and the Ansys deal extends it from electronic design into physics simulation across chips, systems, and products. Management now expects Ansys to contribute about $2.96 billion of fiscal 2026 revenue including accounting impacts, with roughly half of committed cost synergies realized by fiscal year-end.

The raise is the tell that integration is running ahead of plan: full-year guidance moved up to $9.625 to $9.705 billion of revenue with non-GAAP EPS of $14.72 to $14.80, up $0.34 at the midpoint, and a 41 percent midpoint non-GAAP operating margin. Notably, the forward-growth valuation methods, the only family that can see past the deal-year accounting, land above today's price, roughly 20 percent above it at their central read. The concessions are real: $7.55 billion of net debt and a share count up about 5.3 percent a year from deal financing. But the debt sits against one of software's most defensible recurring revenue bases, and every AI-driven design start, every foundry node transition, and every system company designing its own silicon adds to the toll traffic.

Bear Case

The qualitative problem comes first: Synopsys spent roughly $17.6 billion in cash for Ansys stock as part of an aggregate consideration disclosed in its own 10-K (accession 0000883241-25-000028), and in doing so traded the cleanest balance sheet in design software for a leveraged integration story, right as the numbers it reports became hardest to read. The disconnect between price and demonstrated fundamentals is now extreme on every static lens: at $445.46 the market pays about 108 times record-basis trailing operating income, and roughly 6 to 7 times what the earnings-power and asset-value methods would support, with peer multiples about a third of the price. The market has decided the deal-year accounting is noise. That is a reasonable thesis and an unfalsifiable one for several more quarters, which is exactly what should make a buyer uncomfortable.

The balance sheet has changed character. Net debt stands at $7.55 billion against just $2.48 billion of liquid assets, and on EDGAR's trailing GAAP tally, operating income covers interest expense only about 1.0 times (the record-basis measure reads higher at about $1.06 billion of trailing operating income; the two are different measurement bases, both labeled here). The share count has grown about 5.3 percent a year over four years, so the acquisition currency dilutes while the debt constrains. None of this is distress, but it removes the margin for error a 100-plus multiple assumes: the priced-in path requires operating growth near the self-funding ceiling for about 17 years, a persistence only about 15 percent of comparable fast growers managed even ten.

The strategic risks are disclosed, specific, and geopolitical. The 10-K flags that the company is "subject to governmental export and import requirements that could subject us to liability and restrict our ability to sell our products and services" (accession 0000883241-25-000028), and China exposure in EDA has already proven policy-sensitive in recent years; the filing separately warns that any new "trade barrier in any area where we do business could reduce customer demand and cause customers to search for substitute products" (accession 0000883241-25-000028). Layer on the dependency the company itself names, that its tools must remain certified with major foundries or "become less desirable to our customers" (accession 0000883241-25-000028), and the bear is coherent: a levered roll-up of design software priced for two decades of ceiling growth, whose reported earnings cannot yet confirm the story and whose largest swing factors, export policy and AI capex, are outside its control.

Valuation

Two readings of this company disagree violently, and the gap is the analysis. At $445.46 (July 10, 2026), the market pays about 108 times record-basis trailing operating income of roughly $1.06 billion, and EDGAR's GAAP tally is lower still at $610 million as Ansys purchase accounting flows through (different measurement bases, both labeled, neither substituted). Inverted at a 9.6 percent cost of capital, the price implies operating growth held at the self-funding ceiling for about 17 years, a duration only about 15 percent of comparable fast growers sustained even ten. On trailing profits, this is one of the most demanding prices in the coverage universe.

The methods sort themselves by whether they can see through the deal year. Earnings-power and asset-value reads sit at roughly a sixth of the price, peer multiples at about a third, but the forward-growth family, the one lens that discounts the combined company's future cash flows rather than its transition-year accounting, lands about 20 percent above the quote. That inversion of the usual pattern is the story: if fiscal 2026 guidance is the true baseline, revenue of $9.625 to $9.705 billion with a 41 percent midpoint non-GAAP operating margin as the company defines it, then normalized operating economics are multiples of the trailing GAAP figure, and the effective multiple on those economics is far more ordinary. The filing-sourced inputs are the segment architecture, the Design Automation segment spanning "the EDA, Ansys and Other revenue groups" (accession 0000883241-25-000028), and the disclosed Ansys consideration including "Cash for outstanding Ansys Common Stock" of $17.6 billion (accession 0000883241-25-000028), which is the balance-sheet cost of the growth being capitalized.

Solvency is the constraint to respect: $7.55 billion of net debt, liquid assets of $2.48 billion, interest coverage near 1.0 times on the depressed GAAP basis, and dilution running above 5 percent a year. The company is not burning cash, and recurring time-based revenue makes the debt serviceable, but the downside scenario is specific: if AI design demand or Ansys synergies disappoint, the market re-reads the company on transition-year numbers with transition-year leverage. What the buyer underwrites is that fiscal 2026's guided economics, not the trailing GAAP prints, are the real Synopsys.

Catalysts

The May 27, 2026 fiscal second-quarter report reset the year upward: revenue of $2.276 billion exceeded the company's guidance, the EDA segment grew 8 percent year over year, and non-GAAP EPS came in at $3.35 with a 39.5 percent non-GAAP operating margin, all amid robust AI-driven design demand. Management raised full-year fiscal 2026 guidance to revenue of $9.625 to $9.705 billion, a 41 percent midpoint non-GAAP operating margin (up 50 basis points from prior guidance), and non-GAAP EPS of $14.72 to $14.80, up $0.34 at the midpoint.

Ansys integration is the multi-quarter storyline. The company expects approximately half of committed cost synergies to be realized by the end of fiscal 2026, with Ansys contributing about $2.96 billion of fiscal 2026 revenue including purchase-accounting effects. Each quarterly print between now and fiscal year-end (October) is effectively a synergy progress report, and the market's willingness to look through deal-year GAAP depends on those milestones landing.

The next dated event is the fiscal third-quarter report expected in late August 2026. Beyond the print, the external variables that most move the thesis are export policy toward China, which the company's own risk factors flag as capable of restricting sales (accession 0000883241-25-000028), and the pace of AI-related design starts among semiconductor and systems customers, which drives EDA bookings. The stock has traded up on integration momentum since the May report, so the bar for the August print is a continuation, not a surprise.

Peer Cohorts (Per Segment, With Filing Citations)

Design Automation (reported)

• CDNS (CADENCE DESIGN SYSTEMS, INC.)
• (no filing in the citation store)
• ADSK (AUTODESK, INC.)
• (no filing in the citation store)
• PTC (PTC Inc.)
• (no filing in the citation store)

Design IP (reported)

• ARM (ARM)
• (no filing in the citation store)
• RMBS (RAMBUS INC)
• (no filing in the citation store)
• IDCC (INTERDIGITAL, INC.)
• (no filing in the citation store)

Methodology Note

• Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
• Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
• Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
• Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

fiscal Q2 2026 earnings call, May 2026 · fiscal Q2 2026 earnings release, May 2026 · fiscal Q2 2026 earnings release and call, May 27, 2026 · QuiverQuant coverage, 2026